NCT03761914 2024-11-19Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersSellas Life Sciences GroupPhase 1/2 Completed26 enrolled 14 charts
NCT01265433 2024-10-09Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapySellas Life Sciences GroupPhase 2 Completed41 enrolled 12 charts